# Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules

> **NCT01401855** · — · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 300 (actual)

## Conditions studied

- Cancer
- Thyroid

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01401855
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2016-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01401855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01401855, "Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01401855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*